or Try an Advanced Search...

    Technical Analysis for PTPI - Petros Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.34 -8.19% -0.03
    PTPI closed down 8.19 percent on Friday, November 1, 2024, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PTPI trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    20 DMA Support Bullish -8.19%
    50 DMA Support Bullish -8.19%
    Outside Day Range Expansion -8.19%
    Wide Bands Range Expansion -8.19%
    Older End-of-Day Signals for PTPI ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 18 hours ago
    2x Volume Pace about 21 hours ago
    1.5x Volume Pace about 21 hours ago
    Down 5% about 21 hours ago
    Down 3% about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PTPI Chart by TradingView
    Basic chart:

    Profile

    Petros is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to ED, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and chronic), hormone health and substance use disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Disease Disorders Dysfunction Chronic Condition Petros Men's Health Psychosocial

    Is PTPI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 11 Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
    Sep 3 Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 17 Petros Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
    Jul 29 Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
    Jul 16 Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
    May 29 Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch
    May 14 Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
    May 14 Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
    May 3 Petros Pharmaceuticals files $100M mixed securities shelf
    See more PTPI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.27
    52 Week Low 0.2821
    Average Volume 176,502
    200-Day Moving Average 0.71
    50-Day Moving Average 0.35
    20-Day Moving Average 0.35
    10-Day Moving Average 0.38
    Average True Range 0.05
    RSI (14) 47.09
    ADX 17.79
    +DI 18.70
    -DI 18.00
    Chandelier Exit (Long, 3 ATRs) 0.30
    Chandelier Exit (Short, 3 ATRs) 0.43
    Upper Bollinger Bands 0.42
    Lower Bollinger Band 0.28
    Percent B (%b) 0.42
    BandWidth 37.80
    MACD Line 0.01
    MACD Signal Line 0.00
    MACD Histogram 0.0013
    Fundamentals Value
    Market Cap 747.7 Thousand
    Num Shares 2.2 Million
    EPS -6.21
    Price-to-Earnings (P/E) Ratio -0.05
    Price-to-Sales 0.44
    Price-to-Book 0.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.43
    Resistance 3 (R3) 0.43 0.40 0.41
    Resistance 2 (R2) 0.40 0.38 0.40 0.41
    Resistance 1 (R1) 0.37 0.37 0.36 0.37 0.40
    Pivot Point 0.34 0.34 0.34 0.34 0.34
    Support 1 (S1) 0.31 0.32 0.30 0.31 0.28
    Support 2 (S2) 0.29 0.31 0.28 0.27
    Support 3 (S3) 0.25 0.29 0.27
    Support 4 (S4) 0.25